ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, today announced that current Chief Executive Officer, William M. Caldwell IV, has been appointed to serve as the Chairman of the Board in a unanimous vote by the company’s directors.
